OKYO Pharma (OKYO) Current Leases (2021)
OKYO Pharma's (OKYO) quarterly Current Leases came in at $34.1 billion in Q1 2021.
Powered by 
Analysis
OKYO Pharma (OKYO) Current Leases (2021) Analysis & Trends
OKYO Pharma (OKYO) has reported Current Leases for 1 consecutive years, with $34.1 billion the latest figure, recorded in Q1 2021.
- On a quarterly basis, Current Leases changed N/A year-over-year to $34.1 billion in Q1 2021; TTM through Mar 2021 was $34.1 billion, a N/A change from a year earlier, with the FY2021 full-year figure at $34.1 billion, changed N/A from the prior year.
- Current Leases was $34.1 billion for Q1 2021 at OKYO Pharma.
- Over five years, Current Leases peaked at $34.1 billion in Q1 2021 and troughed at $34.1 billion in Q1 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.34 Bn | 192.35 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 180.06 Bn | 176.88 Bn | 6.22 Bn | - |
| 3 | Vertex Pharmaceuticals | 131.22 Bn | 123.37 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 81.84 Bn | 73.84 Bn | 3.93 Bn | 720.00 Mn |
| 5 | Argenx Se | 60.28 Bn | 55.09 Bn | 1.37 Bn | 11.00 Mn |
| 6 | Moderna | 54.18 Bn | 49.05 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 33.22 Bn | 29.91 Bn | 992.69 Mn | 45.93 Mn |
| 8 | Biogen | 31.84 Bn | 30.56 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 29.06 Bn | 29.06 Bn | 1.16 Mn | 12.38 Mn |
| 10 | OKYO Pharma | 955.33 Mn | 955.33 Mn | - | - |